Wednesday, April 7, 2010 as of 11:14 AM ET
Medtronic, Inc. (), based in suburban Minneapolis, Minnesota, is the world's largest medical technology company and is a Fortune 500 company.
Read More at Wikipedia ›Medtronic Inc.
's (MDT) fiscal fourth-quarter earnings rose 28% as the medical-device maker reported fewer charges and broad revenue growth.Chairman and Chief Executive Omar Ishrak said the revenue growth was broad based across its businesses and geographies and included stong product introductions and growth in emerging markets--where revenue climbed 20% excluding currency fluctuations.However, Medtronic has continued to see challenges in its key cardiac-rhythm and spine segments though the company saw some signs of stabilization in recent quarters. In the latest quarter, revenue from implantable cardioverter defibrillators declined 1% excluding currency impacts, while spinal segment revenue was off by 6%.For the quarter ended April 27, Medtronic reported a profit of $991 million, or 94 cents a share, up from $776 million, or 72 cents a share, a year earlier. Excluding litigation-settlement charges, restructuring charges and other items, earnings were up at 99 cents from 90 cents.Reven...Boston Scientific Corp.'s (BSX) first-quarter earnings more than doubled as the medical-device maker posted fewer charges, though revenue declined amid a tough marke...
DOW JONES NEWSWIRESAn emerging treatment for severe high blood pressure marketed by Medtronic Inc. (MDT) showed safety and effectiveness at one and three years in se...
Patients treated with a catheter-delivered heart valve marketed by Medtronic Inc. (MDT) had improvement in valve function and low rates of mortality and stroke at on...
DOW JONES NEWSWIRESPatients treated with a catheter-delivered heart valve marketed by Medtronic Inc. (MDT) had improvement in valve function but saw higher rates of ...
A range of companies is tapping the U.S. credits markets on signs that investor demand for risky assets is holding up, particularly after the Federal Reserve said 15...
A small percentage of Medtronic Inc.'s (MDT) heart devices may have problems where battery life depletes faster than expected, the company said in an online advisory...
Medtronic Inc.'s (MDT) fiscal third-quarter earnings rose 1.2%, with the medical device maker benefiting from fewer charges and the impact of divesting its Physio-Co...
Medtronic (NYSE:MDT) reported slightly higher sales and profit in the third-quarter but continued to struggle with soft demand for its implantable heart defibrillato...
Medtronic Inc. reported net profit of $935 million, or 88 cents a share, for the third quarter ended Jan. 27, up from $924 million, or 86 cents, earned in the same p...
DOW JONES NEWSWIRESThe U.S. Food and Drug Administration approved a new Medtronic Inc. (MDT) heart stent for treatment of coronary artery disease, the company said F...
Don't expect sales of devices that shock the heart to get a jolt anytime soon.The domestic market for implantable cardioverter defibrillators, or ICDs, slumped an es...
A federal court judge has denied Medtronic Inc.'s (MDT) effort to seek a permanent injunction against spinal-product competitor NuVasive Inc. (NUVA), plus other moti...
Medtronic Inc. said on Tuesday that its fiscal fourth-quarter profit roses to $991 million, or 95 cents per share, from $776 million, or 73 cents a share a year ago....
St. Jude Riata leads perform worse than competitor leads in study- Data collected retrospectively from seven centers- St. Jude stopped selling Riata in 2010NEW YORK ...
Medtronic Inc. (MDT) said a clinical trial of its cardiac devices showed detection time in the devices can be extended without risking the health of patients, findin...
St. Jude Medical Inc.'s (STJ) Riata defibrillator leads performed significantly worse than Medtronic Inc.'s (MDT) Quattro leads, according to results from a multicen...
A federal advisory panel backed a new type of implantable heart defibrillator being developed by Cameron Health Inc., saying it represents an additional treatment op...
The Food and Drug Administration Monday said patients receiving a new type of heart defibrillator being developed by Cameron Health Inc. had higher rates of infectio...
Boston Scientific Corp.'s (BSX) first-quarter earnings more than doubled as the medical-device maker posted fewer charges and suggested that declines in its heart rh...